XML 104 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation - Certain Information Regarding Company's Share-Based Compensation (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense, Total $ 5,006 $ 4,727 $ 5,815
Deferred tax benefits, Total 522 513 832
Realized tax benefits, Total 790 286 654
Excess tax benefits (shortfall) 20 (222) (661)
Intrinsic value of options exercised 315 0 0
Cash received for strike price and tax withholdings $ 41 $ 61 $ 84
Shares acquired through cashless exercise 104 36 69
Value of shares acquired through cashless exercise $ 339 $ 418 $ 1,056
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense, Stock options 996 1,882 2,390
Deferred tax benefits, Total 41 126 226
Realized tax benefits, Total 82 0 0
Excess tax benefits (shortfall) $ 7 $ (88) $ (600)
Weighted average fair value per option or share, Stock option grants (in USD per share) $ 0 $ 1.64 $ 2.66
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense $ 588 $ 372 $ 0
Deferred tax benefits, Total 0 0 0
Realized tax benefits, Total 207 0 0
Excess tax benefits (shortfall) $ 47 $ 0 $ 0
Granted, weighted average grant date fair value (in USD per share) $ 16.23 $ 12.32 $ 0
Fair value of restricted stock vested $ 843 $ 0 $ 0
Performance Share Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 868 466 671
Deferred tax benefits, Total 0 0 0
Realized tax benefits, Total 0 0 64
Excess tax benefits (shortfall) $ 0 $ 0 $ (76)
Granted, weighted average grant date fair value (in USD per share) $ 18.26 $ 12.19 $ 14.68
Fair value of performance share units vested $ 164 $ 386 $ 925
Restricted Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation expense 2,554 2,007 2,754
Deferred tax benefits, Total 481 387 606
Realized tax benefits, Total 501 286 590
Excess tax benefits (shortfall) $ (34) $ (134) $ 15
Granted, weighted average grant date fair value (in USD per share) $ 16.68 $ 9.96 $ 16.79
Fair value of restricted stock units vested $ 3,108 $ 1,310 $ 3,212